BioCatalyst

ARDX — ARDELYX, INC. catalysts

1 verified catalyst event(s) for ARDELYX, INC. (ticker ARDX). Each is linked to its official source. Verified as of 2026-10-23.

Next verified catalyst

2027-02-26 — A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Const · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-26
in 4mo
ESTIMATED
 READOUT
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopa
Phase 3 · Chronic Idiopathic Constipation (CIC)
 ARDX ARDELYX, INC. Tenapanor 5 mg BID, Tenapanor 25 mg BID, ClinicalTrials.gov ↗
✓ Source-checked 2026-10-23
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.